Should men with low-grade prostate cancer skip treatment and opt for active surveillance? That’s the question thousands of aging men must consider as the likelihood they will die from a low-grade prostate cancer diagnosis appears low.
Should men with low-grade prostate cancer skip treatment and opt for active surveillance? That’s the question thousands of aging men must consider as the likelihood they will die from a low-grade prostate cancer diagnosis appears low.
